logo

For the Inventor, By the Inventor

Princeton, NJ, United States of America

Jae Hyun Park

This inventor holds 17 USPTO granted patents and 1 published patent application and 8 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Purdue Pharma L.p., Other. Active years: 2015-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae Hyun Park. Retrieved from https://idiyas.com/inventor/jae-hyun-park-sfcmhaur

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 47(Granted Patents)


Location History:

  • Princeton, NJ (US) (2015 - 2020)
  • Chandler, AZ (US) (2017 - 2021)
  • Gainesville, FL (US) (2022 - 2023)

Company Filing History:

goldMedal16 out of 547 
 
Purdue Pharma L.p.
 patents
silverMedal1 out of 834,659 
Other
 patents

Years Active: 2015-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Indole Derivatives
Isoquinoline Derivatives
Sodium Channel Blockers
Pyrimidine Carboxamides
Morphinan Analogs
Piperidine Derivatives
Benzomorphan Analogs
Peptide Toxins
Azaspiro Derivatives
Nitrogen Containing Compounds
Sodium Channel Peptides
Pyridine Derivatives
17 patents (USPTO):Explore Patents
1. 11834447 - Indole derivatives and use thereof (2023-12-05),
2. 11401258 - Isoquinoline derivatives and use thereof (2022-08-02),
3. 11180502 - Azaspiro[4.5]decane derivatives and use thereof (2021-11-23),
4. 10738026 - Isoquinoline derivatives and use thereof (2020-08-11),
5. 10730866 - Indole derivatives and use thereof (2020-08-04),
6. 10550088 - 6-substituted and 7-substituted morphinan analogs and the use thereof (2020-02-04),
7. 10202382 - Azamorphinan derivatives and use thereof (2019-02-12),
8. 10196364 - Pyrimidine carboxamides as sodium channel blockers (2019-02-05),
9. 9884865 - Azaspiro[4.5] decane derivatives and use thereof (2018-02-06),
10. 9745287 - Pyrimidines and use thereof (2017-08-29),
11. 9718865 - Sodium channel blocking peptides and the use thereof (2017-08-01),
12. 9637458 - Pyrimidine carboxamides as sodium channel blockers (2017-05-02),
13. 9359330 - Substituted piperidines as sodium channel blockers (2016-06-07),
14. 9340504 - Pyridine and piperidine derivatives as novel sodium channel blockers (2016-05-17),
15. 9279003 - Analogs of sodium channel peptide toxin (2016-03-08),

Title: The Innovative Mind of Jae Hyun Park

Introduction

Jae Hyun Park is a prominent inventor based in Princeton, NJ, with a remarkable portfolio of 17 patents to his name. His work focuses primarily on the development of pharmaceuticals aimed at treating pain and related disorders through innovative chemical compounds.

Latest Patents

Among his latest contributions to the field are two significant patents. The first patent pertains to indole derivatives and their applications. This invention outlines indole derivatives of a specific formula alongside pharmaceutically acceptable salts and solvates. These compounds demonstrate potential in treating pain by targeting sodium channels in certain disorders.

The second patent centers on isoquinoline derivatives, which also includes compounds and their respective salts, solvates, hydrates, N-oxides, or diastereomers. Similar to his previous invention, these compounds are designed to address pain management through sodium channel blockade, offering new therapeutic avenues for treatment.

Career Highlights

Jae Hyun Park has had an illustrious career, significantly contributing to the pharmaceutical industry. He has worked with notable companies, most prominently Purdue Pharma L.P., where he played a pivotal role in researching and developing medical innovations that could improve the quality of life for many patients.

Collaborations

Throughout his career, Jae Hyun Park has collaborated with esteemed colleagues, including Laykea Tafesse and Jiangchao Yao. These partnerships highlight his commitment to advancing scientific research and innovation in the pharmaceutical sector. Working alongside skilled professionals enriches the creative process and assures a robust approach to problem-solving in the field.

Conclusion

Jae Hyun Park exemplifies the spirit of innovation and the importance of collaboration in scientific discovery. His patents pave the way for new treatments in pain management and underscore his dedication to improving healthcare outcomes. As he continues to innovate, the medical community eagerly anticipates the impact of his work on future developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…